nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.4	0.691	CbGbCtD
Melatonin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.179	0.309	CbGbCtD
Melatonin—Gastrointestinal tract irritation—Riluzole—amyotrophic lateral sclerosis	0.00883	0.0651	CcSEcCtD
Melatonin—MT3—nerve—amyotrophic lateral sclerosis	0.00879	0.0686	CbGeAlD
Melatonin—MT3—hindbrain—amyotrophic lateral sclerosis	0.00658	0.0514	CbGeAlD
Melatonin—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00652	0.0481	CcSEcCtD
Melatonin—CALR—hindbrain—amyotrophic lateral sclerosis	0.00519	0.0405	CbGeAlD
Melatonin—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0382	CcSEcCtD
Melatonin—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00501	0.037	CcSEcCtD
Melatonin—CALM1—cranial nerve—amyotrophic lateral sclerosis	0.00413	0.0322	CbGeAlD
Melatonin—CALM2—pons—amyotrophic lateral sclerosis	0.0041	0.032	CbGeAlD
Melatonin—CALM1—pons—amyotrophic lateral sclerosis	0.00408	0.0318	CbGeAlD
Melatonin—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0287	CcSEcCtD
Melatonin—MT3—brainstem—amyotrophic lateral sclerosis	0.00377	0.0295	CbGeAlD
Melatonin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0034	0.025	CcSEcCtD
Melatonin—CALR—embryo—amyotrophic lateral sclerosis	0.00325	0.0254	CbGeAlD
Melatonin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00319	0.0235	CcSEcCtD
Melatonin—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00311	0.023	CcSEcCtD
Melatonin—CALR—brainstem—amyotrophic lateral sclerosis	0.00298	0.0232	CbGeAlD
Melatonin—NQO2—hindbrain—amyotrophic lateral sclerosis	0.00293	0.0229	CbGeAlD
Melatonin—ASMT—nervous system—amyotrophic lateral sclerosis	0.00291	0.0227	CbGeAlD
Melatonin—ASMT—central nervous system—amyotrophic lateral sclerosis	0.0028	0.0219	CbGeAlD
Melatonin—CALM2—peripheral nervous system—amyotrophic lateral sclerosis	0.00273	0.0213	CbGeAlD
Melatonin—CALM1—peripheral nervous system—amyotrophic lateral sclerosis	0.00271	0.0212	CbGeAlD
Melatonin—MT3—medulla oblongata—amyotrophic lateral sclerosis	0.00263	0.0205	CbGeAlD
Melatonin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0188	CcSEcCtD
Melatonin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0177	CcSEcCtD
Melatonin—MTNR1A—nervous system—amyotrophic lateral sclerosis	0.00236	0.0184	CbGeAlD
Melatonin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0174	CcSEcCtD
Melatonin—MT3—spinal cord—amyotrophic lateral sclerosis	0.00235	0.0183	CbGeAlD
Melatonin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0169	CcSEcCtD
Melatonin—MTNR1A—central nervous system—amyotrophic lateral sclerosis	0.00227	0.0177	CbGeAlD
Melatonin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00227	0.0167	CcSEcCtD
Melatonin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0166	CcSEcCtD
Melatonin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00225	0.0166	CcSEcCtD
Melatonin—ASMT—brain—amyotrophic lateral sclerosis	0.00222	0.0174	CbGeAlD
Melatonin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00217	0.016	CcSEcCtD
Melatonin—CALM2—nerve—amyotrophic lateral sclerosis	0.00212	0.0166	CbGeAlD
Melatonin—CALM1—nerve—amyotrophic lateral sclerosis	0.00211	0.0165	CbGeAlD
Melatonin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0156	CcSEcCtD
Melatonin—CALR—medulla oblongata—amyotrophic lateral sclerosis	0.00208	0.0162	CbGeAlD
Melatonin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00207	0.0152	CcSEcCtD
Melatonin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0149	CcSEcCtD
Melatonin—MT3—nervous system—amyotrophic lateral sclerosis	0.00198	0.0154	CbGeAlD
Melatonin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0142	CcSEcCtD
Melatonin—MT3—central nervous system—amyotrophic lateral sclerosis	0.0019	0.0149	CbGeAlD
Melatonin—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0019	0.014	CcSEcCtD
Melatonin—MT3—cerebellum—amyotrophic lateral sclerosis	0.00186	0.0145	CbGeAlD
Melatonin—CALR—spinal cord—amyotrophic lateral sclerosis	0.00185	0.0144	CbGeAlD
Melatonin—MTNR1A—brain—amyotrophic lateral sclerosis	0.0018	0.0141	CbGeAlD
Melatonin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0133	CcSEcCtD
Melatonin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00176	0.013	CcSEcCtD
Melatonin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00176	0.013	CcSEcCtD
Melatonin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0127	CcSEcCtD
Melatonin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0124	CcSEcCtD
Melatonin—NQO2—brainstem—amyotrophic lateral sclerosis	0.00168	0.0131	CbGeAlD
Melatonin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0123	CcSEcCtD
Melatonin—ESR1—hindbrain—amyotrophic lateral sclerosis	0.0016	0.0125	CbGeAlD
Melatonin—CALM2—hindbrain—amyotrophic lateral sclerosis	0.00159	0.0124	CbGeAlD
Melatonin—CALM1—hindbrain—amyotrophic lateral sclerosis	0.00158	0.0124	CbGeAlD
Melatonin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0115	CcSEcCtD
Melatonin—CALR—nervous system—amyotrophic lateral sclerosis	0.00156	0.0122	CbGeAlD
Melatonin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00156	0.0115	CcSEcCtD
Melatonin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0114	CcSEcCtD
Melatonin—MT3—brain—amyotrophic lateral sclerosis	0.00151	0.0118	CbGeAlD
Melatonin—CALR—central nervous system—amyotrophic lateral sclerosis	0.0015	0.0117	CbGeAlD
Melatonin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0109	CcSEcCtD
Melatonin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0108	CcSEcCtD
Melatonin—CALR—cerebellum—amyotrophic lateral sclerosis	0.00147	0.0115	CbGeAlD
Melatonin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0106	CcSEcCtD
Melatonin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0105	CcSEcCtD
Melatonin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0102	CcSEcCtD
Melatonin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0102	CcSEcCtD
Melatonin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00136	0.01	CcSEcCtD
Melatonin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00997	CcSEcCtD
Melatonin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00987	CcSEcCtD
Melatonin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00983	CcSEcCtD
Melatonin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00977	CcSEcCtD
Melatonin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00933	CcSEcCtD
Melatonin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00928	CcSEcCtD
Melatonin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00913	CcSEcCtD
Melatonin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00911	CcSEcCtD
Melatonin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00909	CcSEcCtD
Melatonin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00898	CcSEcCtD
Melatonin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00893	CcSEcCtD
Melatonin—CALR—brain—amyotrophic lateral sclerosis	0.00119	0.00931	CbGeAlD
Melatonin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00877	CcSEcCtD
Melatonin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00865	CcSEcCtD
Melatonin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00865	CcSEcCtD
Melatonin—NQO2—medulla oblongata—amyotrophic lateral sclerosis	0.00117	0.00914	CbGeAlD
Melatonin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00862	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00859	CcSEcCtD
Melatonin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00846	CcSEcCtD
Melatonin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00824	CcSEcCtD
Melatonin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00816	CcSEcCtD
Melatonin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00813	CcSEcCtD
Melatonin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00812	CcSEcCtD
Melatonin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00805	CcSEcCtD
Melatonin—NQO2—spinal cord—amyotrophic lateral sclerosis	0.00104	0.00815	CbGeAlD
Melatonin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00755	CcSEcCtD
Melatonin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0075	CcSEcCtD
Melatonin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00744	CcSEcCtD
Melatonin—ESR1—embryo—amyotrophic lateral sclerosis	0.001	0.00782	CbGeAlD
Melatonin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.001	0.00737	CcSEcCtD
Melatonin—CALM2—embryo—amyotrophic lateral sclerosis	0.000995	0.00777	CbGeAlD
Melatonin—CALM1—embryo—amyotrophic lateral sclerosis	0.000991	0.00773	CbGeAlD
Melatonin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00099	0.0073	CcSEcCtD
Melatonin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00716	CcSEcCtD
Melatonin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00097	0.00715	CcSEcCtD
Melatonin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000962	0.00709	CcSEcCtD
Melatonin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00678	CcSEcCtD
Melatonin—ESR1—brainstem—amyotrophic lateral sclerosis	0.000918	0.00716	CbGeAlD
Melatonin—CALM2—brainstem—amyotrophic lateral sclerosis	0.000912	0.00712	CbGeAlD
Melatonin—CALM1—brainstem—amyotrophic lateral sclerosis	0.000908	0.00709	CbGeAlD
Melatonin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00655	CcSEcCtD
Melatonin—NQO2—nervous system—amyotrophic lateral sclerosis	0.00088	0.00687	CbGeAlD
Melatonin—NQO2—central nervous system—amyotrophic lateral sclerosis	0.000847	0.00661	CbGeAlD
Melatonin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00611	CcSEcCtD
Melatonin—NQO2—cerebellum—amyotrophic lateral sclerosis	0.000828	0.00646	CbGeAlD
Melatonin—CALM3—medulla oblongata—amyotrophic lateral sclerosis	0.00081	0.00632	CbGeAlD
Melatonin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000807	0.00595	CcSEcCtD
Melatonin—MPO—spinal cord—amyotrophic lateral sclerosis	0.000803	0.00627	CbGeAlD
Melatonin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00587	CcSEcCtD
Melatonin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00548	CcSEcCtD
Melatonin—CALM3—spinal cord—amyotrophic lateral sclerosis	0.000722	0.00564	CbGeAlD
Melatonin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00527	CcSEcCtD
Melatonin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00523	CcSEcCtD
Melatonin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000708	0.00522	CcSEcCtD
Melatonin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000704	0.00519	CcSEcCtD
Melatonin—MPO—nervous system—amyotrophic lateral sclerosis	0.000677	0.00529	CbGeAlD
Melatonin—NQO2—brain—amyotrophic lateral sclerosis	0.000672	0.00525	CbGeAlD
Melatonin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000668	0.00492	CcSEcCtD
Melatonin—MPO—central nervous system—amyotrophic lateral sclerosis	0.000652	0.00509	CbGeAlD
Melatonin—CALM2—medulla oblongata—amyotrophic lateral sclerosis	0.000636	0.00497	CbGeAlD
Melatonin—CALM1—medulla oblongata—amyotrophic lateral sclerosis	0.000633	0.00494	CbGeAlD
Melatonin—CALM3—cerebellum—amyotrophic lateral sclerosis	0.000573	0.00447	CbGeAlD
Melatonin—CALM2—spinal cord—amyotrophic lateral sclerosis	0.000567	0.00443	CbGeAlD
Melatonin—CALM1—spinal cord—amyotrophic lateral sclerosis	0.000565	0.00441	CbGeAlD
Melatonin—CYP19A1—nervous system—amyotrophic lateral sclerosis	0.000553	0.00432	CbGeAlD
Melatonin—SLC22A8—nervous system—amyotrophic lateral sclerosis	0.000541	0.00423	CbGeAlD
Melatonin—CYP19A1—central nervous system—amyotrophic lateral sclerosis	0.000533	0.00416	CbGeAlD
Melatonin—SLC22A8—central nervous system—amyotrophic lateral sclerosis	0.000521	0.00407	CbGeAlD
Melatonin—MPO—brain—amyotrophic lateral sclerosis	0.000517	0.00404	CbGeAlD
Melatonin—CYP1B1—nervous system—amyotrophic lateral sclerosis	0.000517	0.00404	CbGeAlD
Melatonin—CYP1B1—central nervous system—amyotrophic lateral sclerosis	0.000498	0.00389	CbGeAlD
Melatonin—CYP1B1—cerebellum—amyotrophic lateral sclerosis	0.000487	0.0038	CbGeAlD
Melatonin—ESR1—nervous system—amyotrophic lateral sclerosis	0.000481	0.00375	CbGeAlD
Melatonin—CALM2—nervous system—amyotrophic lateral sclerosis	0.000478	0.00373	CbGeAlD
Melatonin—CALM1—nervous system—amyotrophic lateral sclerosis	0.000476	0.00371	CbGeAlD
Melatonin—CALM3—brain—amyotrophic lateral sclerosis	0.000465	0.00363	CbGeAlD
Melatonin—ESR1—central nervous system—amyotrophic lateral sclerosis	0.000463	0.00361	CbGeAlD
Melatonin—CALM2—central nervous system—amyotrophic lateral sclerosis	0.00046	0.00359	CbGeAlD
Melatonin—CALM1—central nervous system—amyotrophic lateral sclerosis	0.000458	0.00358	CbGeAlD
Melatonin—ESR1—cerebellum—amyotrophic lateral sclerosis	0.000452	0.00353	CbGeAlD
Melatonin—CALM2—cerebellum—amyotrophic lateral sclerosis	0.00045	0.00351	CbGeAlD
Melatonin—CALM1—cerebellum—amyotrophic lateral sclerosis	0.000448	0.00349	CbGeAlD
Melatonin—CYP19A1—brain—amyotrophic lateral sclerosis	0.000423	0.0033	CbGeAlD
Melatonin—SLC22A8—brain—amyotrophic lateral sclerosis	0.000414	0.00323	CbGeAlD
Melatonin—CYP1B1—brain—amyotrophic lateral sclerosis	0.000395	0.00309	CbGeAlD
Melatonin—ESR1—brain—amyotrophic lateral sclerosis	0.000367	0.00287	CbGeAlD
Melatonin—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000366	0.00285	CbGeAlD
Melatonin—CALM2—brain—amyotrophic lateral sclerosis	0.000365	0.00285	CbGeAlD
Melatonin—CALM1—brain—amyotrophic lateral sclerosis	0.000364	0.00284	CbGeAlD
Melatonin—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000352	0.00275	CbGeAlD
Melatonin—Nabumetone—PTGS2—amyotrophic lateral sclerosis	0.000282	1	CrCbGaD
Melatonin—CYP1A1—brain—amyotrophic lateral sclerosis	0.000279	0.00218	CbGeAlD
Melatonin—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	3.24e-05	0.000206	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.23e-05	0.000206	CbGpPWpGaD
Melatonin—CALM3—Disease—VCP—amyotrophic lateral sclerosis	3.23e-05	0.000206	CbGpPWpGaD
Melatonin—CALM3—Immune System—DCTN1—amyotrophic lateral sclerosis	3.2e-05	0.000204	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—ATF1—amyotrophic lateral sclerosis	3.18e-05	0.000203	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—ATF1—amyotrophic lateral sclerosis	3.18e-05	0.000203	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.15e-05	0.0002	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	3.15e-05	0.0002	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	3.14e-05	0.0002	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	3.13e-05	0.000199	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—CASP9—amyotrophic lateral sclerosis	3.13e-05	0.000199	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.12e-05	0.000199	CbGpPWpGaD
Melatonin—CALM2—Disease—VCP—amyotrophic lateral sclerosis	3.12e-05	0.000199	CbGpPWpGaD
Melatonin—CALM1—Disease—VCP—amyotrophic lateral sclerosis	3.12e-05	0.000199	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.12e-05	0.000199	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	3.11e-05	0.000198	CbGpPWpGaD
Melatonin—CALM2—Immune System—DCTN1—amyotrophic lateral sclerosis	3.09e-05	0.000197	CbGpPWpGaD
Melatonin—CALM1—Immune System—DCTN1—amyotrophic lateral sclerosis	3.09e-05	0.000197	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.06e-05	0.000195	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PLB1—amyotrophic lateral sclerosis	3.03e-05	0.000193	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—CASP9—amyotrophic lateral sclerosis	3.03e-05	0.000193	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	3.03e-05	0.000193	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.02e-05	0.000192	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.02e-05	0.000192	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	3.01e-05	0.000192	CbGpPWpGaD
Melatonin—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.94e-05	0.000187	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.94e-05	0.000187	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.94e-05	0.000187	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	2.91e-05	0.000185	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	2.91e-05	0.000185	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.88e-05	0.000183	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.85e-05	0.000181	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.83e-05	0.00018	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.8e-05	0.000178	CbGpPWpGaD
Melatonin—CALM3—Metabolism—GSR—amyotrophic lateral sclerosis	2.8e-05	0.000178	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	2.79e-05	0.000177	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.75e-05	0.000175	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.71e-05	0.000172	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.71e-05	0.000172	CbGpPWpGaD
Melatonin—CALM2—Metabolism—GSR—amyotrophic lateral sclerosis	2.71e-05	0.000172	CbGpPWpGaD
Melatonin—CALM1—Metabolism—GSR—amyotrophic lateral sclerosis	2.71e-05	0.000172	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.68e-05	0.000171	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.68e-05	0.00017	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.66e-05	0.000169	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.65e-05	0.000168	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.65e-05	0.000168	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.6e-05	0.000165	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.6e-05	0.000165	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.58e-05	0.000164	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.54e-05	0.000161	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.5e-05	0.000159	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.5e-05	0.000159	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.49e-05	0.000159	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.49e-05	0.000159	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.45e-05	0.000156	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.45e-05	0.000156	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.42e-05	0.000154	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.42e-05	0.000154	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.42e-05	0.000154	CbGpPWpGaD
Melatonin—CALM3—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.41e-05	0.000154	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.39e-05	0.000152	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.36e-05	0.00015	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.34e-05	0.000149	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.34e-05	0.000149	CbGpPWpGaD
Melatonin—CALM1—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.33e-05	0.000149	CbGpPWpGaD
Melatonin—CALM2—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.33e-05	0.000149	CbGpPWpGaD
Melatonin—CALM3—Disease—CST3—amyotrophic lateral sclerosis	2.32e-05	0.000148	CbGpPWpGaD
Melatonin—CALM3—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.31e-05	0.000147	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.31e-05	0.000147	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.31e-05	0.000147	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.3e-05	0.000146	CbGpPWpGaD
Melatonin—CALM3—Metabolism—CHAT—amyotrophic lateral sclerosis	2.3e-05	0.000146	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.26e-05	0.000144	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.25e-05	0.000143	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.25e-05	0.000143	CbGpPWpGaD
Melatonin—CALM2—Disease—CST3—amyotrophic lateral sclerosis	2.24e-05	0.000143	CbGpPWpGaD
Melatonin—CALM1—Disease—CST3—amyotrophic lateral sclerosis	2.24e-05	0.000143	CbGpPWpGaD
Melatonin—CALM1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.24e-05	0.000142	CbGpPWpGaD
Melatonin—CALM2—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.24e-05	0.000142	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—C3—amyotrophic lateral sclerosis	2.23e-05	0.000142	CbGpPWpGaD
Melatonin—CALM2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000142	CbGpPWpGaD
Melatonin—CALM1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.22e-05	0.000142	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.22e-05	0.000141	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.19e-05	0.000139	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.19e-05	0.000139	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.19e-05	0.000139	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.18e-05	0.000139	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.17e-05	0.000138	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—C3—amyotrophic lateral sclerosis	2.16e-05	0.000137	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—C3—amyotrophic lateral sclerosis	2.16e-05	0.000137	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	2.15e-05	0.000137	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.14e-05	0.000136	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.12e-05	0.000135	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.12e-05	0.000135	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.07e-05	0.000132	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	2.07e-05	0.000132	CbGpPWpGaD
Melatonin—CALM3—Immune System—SQSTM1—amyotrophic lateral sclerosis	2.04e-05	0.00013	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.99e-05	0.000127	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.98e-05	0.000126	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	0.000126	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.98e-05	0.000126	CbGpPWpGaD
Melatonin—CALM2—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.98e-05	0.000126	CbGpPWpGaD
Melatonin—CALM1—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.98e-05	0.000126	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.94e-05	0.000124	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.92e-05	0.000122	CbGpPWpGaD
Melatonin—CALM3—Immune System—ATF1—amyotrophic lateral sclerosis	1.92e-05	0.000122	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.9e-05	0.000121	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.9e-05	0.000121	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.89e-05	0.00012	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.88e-05	0.00012	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.88e-05	0.00012	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.86e-05	0.000118	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.86e-05	0.000118	CbGpPWpGaD
Melatonin—CALM2—Immune System—ATF1—amyotrophic lateral sclerosis	1.85e-05	0.000118	CbGpPWpGaD
Melatonin—CALM1—Immune System—ATF1—amyotrophic lateral sclerosis	1.85e-05	0.000118	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.84e-05	0.000117	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—IGF1—amyotrophic lateral sclerosis	1.84e-05	0.000117	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.84e-05	0.000117	CbGpPWpGaD
Melatonin—CALM3—Immune System—CASP9—amyotrophic lateral sclerosis	1.83e-05	0.000116	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.82e-05	0.000116	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.81e-05	0.000115	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.79e-05	0.000114	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.78e-05	0.000113	CbGpPWpGaD
Melatonin—CALM1—Immune System—CASP9—amyotrophic lateral sclerosis	1.77e-05	0.000112	CbGpPWpGaD
Melatonin—CALM2—Immune System—CASP9—amyotrophic lateral sclerosis	1.77e-05	0.000112	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.75e-05	0.000111	CbGpPWpGaD
Melatonin—MTNR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.7e-05	0.000108	CbGpPWpGaD
Melatonin—MTNR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.7e-05	0.000108	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.69e-05	0.000108	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.69e-05	0.000108	CbGpPWpGaD
Melatonin—CALM3—Disease—CASP9—amyotrophic lateral sclerosis	1.69e-05	0.000107	CbGpPWpGaD
Melatonin—CALM1—Disease—CASP9—amyotrophic lateral sclerosis	1.63e-05	0.000104	CbGpPWpGaD
Melatonin—CALM2—Disease—CASP9—amyotrophic lateral sclerosis	1.63e-05	0.000104	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.63e-05	0.000104	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.63e-05	0.000104	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000102	CbGpPWpGaD
Melatonin—CALM3—Immune System—ERBB4—amyotrophic lateral sclerosis	1.56e-05	9.94e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	9.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	9.9e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.54e-05	9.82e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—ERBB4—amyotrophic lateral sclerosis	1.51e-05	9.62e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—ERBB4—amyotrophic lateral sclerosis	1.51e-05	9.62e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.5e-05	9.52e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.49e-05	9.45e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—CD40LG—amyotrophic lateral sclerosis	1.47e-05	9.35e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.45e-05	9.21e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—ERBB4—amyotrophic lateral sclerosis	1.44e-05	9.18e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.44e-05	9.16e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—CD40LG—amyotrophic lateral sclerosis	1.42e-05	9.04e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—CD40LG—amyotrophic lateral sclerosis	1.42e-05	9.04e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.42e-05	9.04e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—ERBB4—amyotrophic lateral sclerosis	1.4e-05	8.88e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—ERBB4—amyotrophic lateral sclerosis	1.4e-05	8.88e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.39e-05	8.85e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.37e-05	8.75e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.37e-05	8.75e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.36e-05	8.68e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.36e-05	8.66e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.32e-05	8.41e-05	CbGpPWpGaD
Melatonin—CALM3—Immune System—C3—amyotrophic lateral sclerosis	1.3e-05	8.26e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.28e-05	8.13e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.28e-05	8.13e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.27e-05	8.08e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—C3—amyotrophic lateral sclerosis	1.26e-05	7.99e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—C3—amyotrophic lateral sclerosis	1.26e-05	7.99e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.24e-05	7.92e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.24e-05	7.89e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.24e-05	7.87e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.2e-05	7.66e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.2e-05	7.66e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.2e-05	7.65e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.2e-05	7.63e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.2e-05	7.63e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.2e-05	7.61e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.2e-05	7.61e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.18e-05	7.51e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.17e-05	7.46e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.14e-05	7.27e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.14e-05	7.27e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.14e-05	7.23e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.12e-05	7.12e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.12e-05	7.1e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—APOE—amyotrophic lateral sclerosis	1.12e-05	7.1e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	6.99e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.1e-05	6.99e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—APOE—amyotrophic lateral sclerosis	1.08e-05	6.87e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—APOE—amyotrophic lateral sclerosis	1.08e-05	6.87e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.08e-05	6.86e-05	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.02e-05	6.52e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.02e-05	6.48e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.01e-05	6.43e-05	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.87e-06	6.28e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.77e-06	6.22e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.77e-06	6.22e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.6e-06	6.11e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.5e-06	6.04e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—TP53—amyotrophic lateral sclerosis	9.4e-06	5.98e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—APOE—amyotrophic lateral sclerosis	9.35e-06	5.95e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.25e-06	5.89e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.19e-06	5.85e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	9.19e-06	5.85e-05	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—TP53—amyotrophic lateral sclerosis	9.09e-06	5.79e-05	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—TP53—amyotrophic lateral sclerosis	9.09e-06	5.79e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—APOE—amyotrophic lateral sclerosis	9.04e-06	5.75e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—APOE—amyotrophic lateral sclerosis	9.04e-06	5.75e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.87e-06	5.64e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.82e-06	5.61e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.75e-06	5.57e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.7e-06	5.54e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.39e-06	5.34e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.12e-06	5.17e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.12e-06	5.17e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.04e-06	5.12e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.81e-06	4.97e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—amyotrophic lateral sclerosis	7.65e-06	4.87e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.56e-06	4.81e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.56e-06	4.81e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.48e-06	4.76e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—amyotrophic lateral sclerosis	7.4e-06	4.71e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—amyotrophic lateral sclerosis	7.4e-06	4.71e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	7.26e-06	4.62e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.12e-06	4.53e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.87e-06	4.37e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.73e-06	4.28e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	6.62e-06	4.21e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.46e-06	4.11e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.4e-06	4.08e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.25e-06	3.98e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.25e-06	3.98e-05	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.19e-06	3.94e-05	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.19e-06	3.94e-05	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.08e-06	3.87e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.04e-06	3.84e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.65e-06	3.6e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.97e-06	3.16e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.97e-06	3.16e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.81e-06	3.06e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.81e-06	3.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.7e-06	2.99e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.56e-06	2.9e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.54e-06	2.89e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.54e-06	2.89e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.53e-06	2.89e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.22e-06	2.68e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.08e-06	2.6e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.08e-06	2.6e-05	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.87e-06	2.47e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.19e-06	2.03e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.08e-06	1.96e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.08e-06	1.96e-05	CbGpPWpGaD
